dianhydrogalactitol has been researched along with Astrocytoma, Grade IV in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Al-Shahrour, F; Curiel-García, Á; Galán-Ganga, M; Jiménez-Alcázar, M; Lowe, SW; Nogales, P; Perales-Patón, J; Schuhmacher, AJ; Squatrito, M; Zhu, L | 1 |
Fu, X; Huang, C; Huang, Y; Jiang, X; Li, F; Li, Y; Liang, Q; Liu, H; Wang, X | 1 |
Espana, P; Walker, MD; Wiernik, PH | 1 |
Bisel, HF; Childs, DS; Eagan, RT; Fleming, TR; Holbrook, MA; Laws, ER; Layton, DD | 1 |
2 trial(s) available for dianhydrogalactitol and Astrocytoma, Grade IV
Article | Year |
---|---|
Phase II study of dianhydrogalactitol in malignant glioma.
Topics: Adult; Aged; Clinical Trials as Topic; Dianhydrogalactitol; Drug Evaluation; Glioblastoma; Humans; Leukopenia; Middle Aged; Sugar Alcohols | 1978 |
Dianhydrogalactitol and radiation therapy. Treatment of supratentorial glioma.
Topics: Adult; Aged; Brain Neoplasms; Dianhydrogalactitol; Female; Glioblastoma; Humans; Leukopenia; Male; Middle Aged; Sugar Alcohols | 1979 |
2 other study(ies) available for dianhydrogalactitol and Astrocytoma, Grade IV
Article | Year |
---|---|
Dianhydrogalactitol Overcomes Multiple Temozolomide Resistance Mechanisms in Glioblastoma.
Topics: Animals; Cell Line, Tumor; Dianhydrogalactitol; Drug Resistance, Neoplasm; Glioblastoma; Humans; Mice; Temozolomide; Transfection; Xenograft Model Antitumor Assays | 2021 |
Dianhydrogalactitol, a potential multitarget agent, inhibits glioblastoma migration, invasion, and angiogenesis.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Cell Line; Cell Line, Tumor; Cell Movement; Cell Proliferation; Dianhydrogalactitol; Glioblastoma; Human Umbilical Vein Endothelial Cells; Humans; Matrix Metalloproteinase 2; Neoplasm Invasiveness; Neovascularization, Pathologic; Proto-Oncogene Proteins; Signal Transduction; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2; Zebrafish | 2017 |